Akzo Nobel India Q2 Results Live: Profit Rises by 3.93% YOY
1 month, 2 weeks ago

Akzo Nobel India Q2 Results Live: Profit Rises by 3.93% YOY

Live Mint  

Akzo Nobel India Q2 Results Live : Akzo Nobel India announced its Q2 results on November 7, 2024, reporting a year-over-year increase in both revenue and profit. However, when compared to the previous quarter, Akzo Nobel India experienced a decline in revenue by 5.21% and a significant drop in profit by 14.57%. As of November 8, 2024, Akzo Nobel India has a market capitalization of ₹19,026.97 crore, with a 52-week high of ₹4,674 and a low of ₹2,267. Akzo Nobel India Financials Period Q2 Q1 Q-o-Q Growth Q2 Y-o-Y Growth Total Revenue 982.3 1036.3 -5.21% 956.3 +2.72% Selling/ General/ Admin Expenses Total 86.8 88.6 -2.03% 82.8 +4.83% Depreciation/ Amortization 22.2 21.8 +1.83% 21.1 +5.21% Total Operating Expense 858.1 889.2 -3.5% 835.6 +2.69% Operating Income 124.2 147.1 -15.57% 120.7 +2.9% Net Income Before Taxes 131.8 154.3 -14.58% 126.9 +3.86% Net Income 97.9 114.6 -14.57% 94.2 +3.93% Diluted Normalized EPS 21.49 25.17 -14.62% 20.7 +3.82%

India Nobel Eps Growth Q2 Akzo  total  india  revenue  performance  income  growth  q2  yoy  results  rises  profit  393  nobel  akzo  live  yearoveryear

History of this topic

Race for Dulux maker tightens to three players
1 week ago

Race for Dulux maker tightens to three players

Live Mint  

The race for Akzo Nobel India Ltd has narrowed to Pidilite Industries Ltd, JSW Paints Pvt. If a deal is struck at a valuation of $2-2.5 billion, it would mark the country's largest takeover in India's paints industry led by Asian Paints, Berger Paints, Akzo Nobel and Kansai Nerolac. Akzo Nobel, which sells Dulux, International, Sikkens and Interpon brands in …

JB Chemicals & Pharmaceuticals Q2 Results Live: Profit Rise by 15.92% YOY
1 month, 2 weeks ago

JB Chemicals & Pharmaceuticals Q2 Results Live: Profit Rise by 15.92% YOY

Live Mint  

JB Chemicals & Pharmaceuticals Q2 Results Live : JB Chemicals & Pharmaceuticals has announced its Q2 results for the fiscal year, revealing a notable increase in profits and revenue. The company declared its financial performance on November 6, 2024, showing a year-over-year revenue growth of 13.48% and a profit increase of 15.92%. Despite the mixed results, JB Chemicals & Pharmaceuticals …

Discover Related